home *** CD-ROM | disk | FTP | other *** search
- $Unique_ID{BRK04282}
- $Pretitle{}
- $Title{Toxoplasmosis}
- $Subject{Toxoplasmosis Lymphadenopathic Toxoplasmosis Disseminated
- Toxoplasmosis }
- $Volume{}
- $Log{}
-
- Copyright (C) 1986, 1987, 1988, 1989, 1993 National Organization for Rare
- Disorders, Inc.
-
- 268:
- Toxoplasmosis
-
- ** IMPORTANT **
- It is possible the main title of the article (Toxoplasmosis) is not the
- name you expected. Please check the SYNONYMS listing to find the alternate
- names and disorder subdivisions covered by this article.
-
- Synonyms
-
- DISORDER SUBDIVISIONS
-
- Lymphadenopathic Toxoplasmosis
- Disseminated Toxoplasmosis
-
- General Discussion
-
- ** REMINDER **
- The information contained in the Rare Disease Database is provided for
- educational purposes only. It should not be used for diagnostic or treatment
- purposes. If you wish to obtain more information about this disorder, please
- contact your personal physician and/or the agencies listed in the "Resources"
- section of this report.
-
-
- Toxoplasmosis is an infectious disease that can be caused by contact with
- a microscopic parasitic organism called Toxoplasma gondii. This parasitic
- infection, found worldwide, can be either acquired or be present at birth
- (congenital). The congenital type is a result of a maternal infection during
- pregnancy which is transmitted to the fetus, and involves lesions of the
- central nervous system. These lesions may lead to blindness, brain defects
- and more serious conditions. The disorder may be most severe when it is
- transmitted to the fetus during the second through sixth month of pregnancy.
- Twenty percent to 80% of those affected will show the presence of
- toxoplasmosis antibodies when tested.
-
- The acquired form includes these two types of Toxoplasmosis:
- 1) Lymphadenopathic Toxoplasmosis is a form of the disorder which
- resembles mononucleosis.
- 2) Disseminated Toxoplasmosis is a form of the disorder in which lesions
- involve chiefly the lungs, liver, heart, skin, muscle, brain, and spinal
- chord membranes (meninges). It is characterized by inflammation of the
- lungs (pneumonitis), hepatitis, inflammation of the muscular walls of the
- heart (myocarditis), and inflammation of the brain and meninges
- (meningoencephalitis), all in varying degrees.
-
- The prognosis for the acquired disease (when of moderate severity) is
- usually good with treatment, and commonly subsides without complications. If
- untreated, this infection may persist for many months, and can cause
- blindness. It is rarely fatal in adults.
-
- Symptoms
-
- Symptoms of Toxoplasmosis may be severe, rapidly appearing, or there may be
- no symptoms at all:
-
- 1) The more common mild form, which may resemble infectious
- mononucleosis, is characterized by a disease of the lymph nodes in the neck
- and armpit area (cervical and axillary lymphadenopathy), a vague feeling of
- discomfort (malaise), muscle pain and irregular low fever. Mild anemia,
- hypotension, reduction of total white blood cells (leukopenia), elevation of
- lymphoid white blood cell count (lymphocytosis), and slightly altered liver
- function may also occur. More commonly, it is a neck area lymph node
- disorder involving no other obvious symptoms (asymptomatic cervical
- lymphadenopathy).
-
- 2) In some cases the disorder may be an acute, suddenly occurring,
- disseminated infection that affects primarily those people who seem to have a
- reduced ability to fight infection. This is usually characterized with a
- rash, high fever, chills, and prostration. Some patients may develop
- inflammation of the lungs (pneumonitis), liver (hepatitis), muscular walls of
- the heart (myocarditis), and possibly inflammation of the brain and possibly
- meninges (meningoencephalitis).
-
- 3) Chronic toxoplasmosis, which causes severe inner eye inflammation
- (retinochoroiditis or posterior uveitis), may be marked by muscular weakness,
- weight loss, headache, and diarrhea. Symptoms are usually vague and
- indefinite making proper diagnosis difficult.
-
- In some cases of toxoplasmosis, confusion and headaches may be the
- primary symptoms.
-
- In the neonatal congenital type of toxoplasmosis, features can be
- variable. Spontaneous abortion (miscarriage) may ensue if the infection
- occurs early in pregnancy. Infection later in pregnancy may result in
- miscarriage or stillbirth, or in the birth of a living child with the
- disease.
-
- Symptoms of subacute toxoplasmosis infection may begin shortly after
- birth, but more often appear months or several years later. Central nervous
- system (CNS) disorders such as hydrocephalus, microcephaly, intracranial
- calcifications, and mental retardation may occur. Skin rashes, enlargement
- of the liver and spleen (hepatosplenomegaly), jaundice and inflammation of
- the choroid and retina of the eye (chorioretinitis) may also be present.
-
- Inflammation of the choroid and retina (chorioretinitis) usually
- accompanies the congenital form and may occur in the acquired forms. Chronic
- disease with relapses can continue to occur in patients who survive the
- subacute phase. Abdominal organ (visceral) lesions, aside from those in the
- liver, are unusual and tend to heal more readily than the central nervous
- systems lesions.
-
- Causes
-
- Toxoplasmosis is an infectious disease which may be either congenital or
- acquired. Several modes of transmission may occur and must be guarded
- against. These include a parasite carried by birds and certain mammals,
- notably cats, cattle, swine, sheep, rabbits, and dogs. The disorder may also
- be transmitted by consumption of under-cooked meat containing the parasitic
- organisms (cysts), or by contact with cat feces containing the encapsulated
- organisms (oocysts). Care must be taken when cleaning the litter boxes of
- infected cats as inadvertent hand-to-mouth contact with the parasite may
- occur. There is also evidence that the infection can be acquired through
- inhalation of the dust arising when cleaning the litter. However, with
- proper hygienic precautions, infection is very unlikely. Flies and/or
- cockroaches may possibly transport the oocysts to human food. In a human
- host, the infection may possibly represent a reactivation of the latent
- disease.
-
- The congenital type of toxoplasmosis is due to the infection being
- contracted during pregnancy and passed on to the fetus. In particular,
- contact with cats and cat feces during pregnancy must be avoided in
- particular to control this occurrence.
-
- Affected Population
-
- Toxoplasmosis affects men and women in equal numbers world wide. The
- occurrence rate in infants is 0.25 - 5.0 per 100,000 live births. This
- disorder also may cause many abortions and still births in areas of the world
- where the disorder may be more prevalent.
-
- Approximately 40% of children with Toxoplasmosis become infected in the
- womb because of maternal infection during pregnancy. Of these children, 15%
- have severe symptoms and 19% have mild symptoms. Fetal damage is most likely
- when the infection occurs during the second to the sixth month of gestation.
- The majority of children born with Toxoplasmosis have no symptoms at birth,
- but show evidence of damage several months to years later. The most common
- abnormalities are eye disease and low I.Q. The estimated frequency of
- Toxoplasmosis during pregnancy is 1.1 cases per 1,000 pregnant women.
- However, maternal Toxoplasmosis acquired a month or longer before the
- pregnancy is rarely transmitted to the fetus.
-
- Related Disorders
-
- Hepatitis is an infectious liver disorder which may be caused by exposure to
- a large variety of infectious agents or substances. Which type of hepatitis
- a patient may have is usually determined by the cause. When hepatitis is
- caused by toxoplasmosis, the liver and spleen are usually involved. (For
- more information on this disorder, choose "Hepatitis" as your search term in
- the Rare Disease Database.)
-
- Encephalitis encompasses a large group of viral infections of the brain
- with a variety of neurological symptoms which depend on the infectious agent.
- Encephalitis in conjunction with toxoplasmosis appears to be transmitted by
- the same carrier.
-
- Therapies: Standard
-
- Acute Toxoplasmosis of newborns, pregnant women, and patients who have had
- their immune response diminished should be treated with antibiotics such as
- trisulfapyrimidines or sulfadiazine, plus pyrimethamine for three to four
- weeks. The toxicity of pyrimethamine can be minimized with the daily
- administration of folinic acid. Since pyrimethamine can produce deformities
- in animal fetuses, sulfonamides alone should be used in pregnant women who
- are treated for toxoplasmosis.
-
- Some patients with Toxoplasmosis do not require specific therapy unless a
- vital organ such as the eyes, brain, or heart is involved, or if other
- symptoms are severe and persistent. Corticosteroids are often useful in
- these situations to control inflammation. Periodic blood counts may be
- obtained during therapy to monitor the toxicity of drugs used for treatment
- of this disorder.
-
- Since sulfadiazine is no longer manufactured in the United States,
- patients can receive the drug through the Centers for Disease Control (CDC).
- To request sulfadiazine, contact CDC's Division of Parasitic Diseases,
- National Center for Infectious Diseases, (404) 488-4928.
-
- Therapies: Investigational
-
- The Food and Drug Administration (FDA) has awarded a research grant to Rima
- McLeod, M.D., Michael Reese Hospital & Medical Center, Chicago, IL, for
- comparison studies on treatments for congenital Toxoplasmosis. Included in
- the studies are the experimental drugs pyrimethanine sulfadiazine,
- spiramycin, and pyrimethamin sulfadoxine.
-
- Research on Toxoplasmosis is ongoing in many parts of the world. For
- information on the latest developments in this research, please contact:
-
- Centers for Disease Control
- 1600 Clifton Rd. NE
- Atlanta, GA 30333.
- (404) 639-3534
-
- For information on additional therapies that have been designated as
- Orphan Drugs in the last few months, please return to the main menu of NORD
- Services and access the Orphan Drug Database.
-
- This disease entry is based upon medical information available through
- April 1993. Since NORD's resources are limited, it is not possible to keep
- every entry in the Rare Disease Database completely current and accurate.
- Please check with the agencies listed in the Resources section for the most
- current information about this disorder.
-
- Resources
-
- For more information on Toxoplasmosis, please contact:
-
- National Organization for Rare Disorders (NORD)
- P.O. Box 8923
- New Fairfield, CT 06812-1783
- (203) 746-6518
-
- Toxoplasmosis Interest Group
- 52 Edgell Street
- Gardner, Mass. 01440
- (617) 632-7783
-
- Centers for Disease Control (CDC)
- 1600 Clifton Road, NE
- Atlanta, GA 30333
- (404) 639-3534
-
- NIH/National Institute of Allergy and Infectious Diseases
- 9000 Rockville Pike
- Bethesda, MD 20892
- (301) 496-5717
-
- References
-
- MERCK MANUAL OF DIAGNOSIS AND THERAPY: Robert Berkow, et al., eds; Merck
- Sharp & Dohme Research Laboratories, 1982. P. 24.
-
-